Since I got into this stock it has only had one good run and that was back in the spring when it went to $4.95.  Shortly after the company cashed-in to the tune of about $15M which in turn drove the price back down.  The demand at that time seemed to come out of nowhere, almost like it was orchestrated for the purpose of facilitating that public offering, but we won’t pursue that conspiracy theory further.

It seems more logical to me that the arguments like the lack of public knowledge for this stock, the fact that it’s a new science, the failed trial a few years ago and again a couple of months ago, etc. are more persuasive reasons why the stock isn’t moving.  Some good news this weekend will surely have some impact but the real payoff, if there is one, may not come until there is a US listing that can promote proven successes to a wider audience, or a buy-out by a BP that has a more intimate knowledge of the company and the science.  The importance of this weekend, and again the cognition results in December. is that RVX needs a marketable foundation on which to build going forward.  If we can get that then we’ll be a lot closer to having an investment that will pay off in the way we all hope.